Clinical Trials

NCT04791358 | ACTIVE_NOT_RECRUITING
1500 participants

Decision Impact Trial of KidneyIntelX

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2021-11-01
Completion:
2026-11-01
Conditions
  • Diabetic Kidney Disease
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04665739 | RECRUITING | PHASE2
70 participants

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2023-02-03
Completion:
2027-07-01
Conditions
  • Advanced Lung Neuroendocrine Tumor
  • Functioning Lung Neuroendocrine Tumor
  • Locally Advanced Lung Neuroendocrine Neoplasm
  • Lung Neuroendocrine Neoplasm
  • Lung Neuroendocrine Tumor G1
  • Lung Neuroendocrine Tumor G2
  • Metastatic Lung Neuroendocrine Neoplasm
  • Metastatic Lung Neuroendocrine Tumor
  • Non-Functioning Lung Neuroendocrine Tumor
  • Recurrent Lung Neuroendocrine Neoplasm
  • Unresectable Lung Neuroendocrine Neoplasm
  • Unresectable Lung Neuroendocrine Tumor
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT04522336 | COMPLETED | PHASE1
16 participants

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2020-09-16
Completion:
2026-08-07
Conditions
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Localized Gastroesophageal Junction Adenocarcinoma
  • Locally Advanced Gastroesophageal Junction Adenocarcinoma
  • Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT04431024 | RECRUITING
300 participants

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-13
Start Date:
2021-03-30
Completion:
2038-06-30
Conditions
  • Familial Cancer
  • BRCA1-Associated Protein-1 (BAP1) Mutations
  • Tumor Predisposition Syndrome (TPDS)
  • Mesothelioma
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page